IMMUNOPRECISE ANTIBODIES LTD's ticker is and the CUSIP is 45257F900. A total of 3 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 400 | -20.0% | 0.00% | – |
Q2 2023 | $1 | -98.9% | 500 | -98.5% | 0.00% | – |
Q1 2023 | $93 | -69.4% | 33,900 | -42.1% | 0.00% | – |
Q4 2022 | $304 | -99.8% | 58,500 | +20.9% | 0.00% | – |
Q3 2022 | $193,000 | -47.3% | 48,400 | -49.8% | 0.00% | – |
Q2 2022 | $366,000 | -49.0% | 96,500 | -30.8% | 0.00% | -100.0% |
Q1 2022 | $717,000 | +94.8% | 139,500 | +102.8% | 0.00% | – |
Q4 2021 | $368,000 | +26.0% | 68,800 | +43.6% | 0.00% | – |
Q3 2021 | $292,000 | +1.4% | 47,900 | 0.0% | 0.00% | – |
Q2 2021 | $288,000 | – | 47,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 63,700 | $341,000 | 0.00% |
SIMPLEX TRADING, LLC | 68,800 | $368,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |